PDF herunterladen
Thromb Haemost 1998; 80(02): 353
DOI: 10.1055/s-0037-1615210
Letters to the Editor
Schattauer GmbH

Recombinant Factor VIIa in Severe Uremic Bleeding

Tom Révész
1   Department of Haematology
,
Bert Arets
2   Pulmonology and Intensive Care
,
Marc Bierings
1   Department of Haematology
,
Cor van den Bos
1   Department of Haematology
,
Els Duval
3   Intensive Care, Wilhelmina Children’s Hospital, University of Utrecht, The Netherlands
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 18. Februar 1998

Accepted after revision 30. April 1998

Publikationsdatum:
08. Dezember 2017 (online)

Auch verfügbar auf
    Lizenzen und Reprints

 

 

  • References

  • 1 Ingerslev J, Feldstedt M, Sindet-Petersen S. Control of haemostasis with recombinant factor VIIa in a patient with inhibitor to factor VIII.. Lancet 1991; 1: 831-1.
    PubMedGoogle Scholar
  • 2 Kristensen J, Killander A, Hippe E, Helleberg C, Ellegard J, Holm M, Kutti J, Mellquist UH, Johansson JE, Glazer S, Hedner U. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia.. Haemostasis 1996; 26: 159-64.
    PubMedGoogle Scholar
  • 3 Tengborn L, Petruson B. A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa.. Thromb Haemost 1996; 75: 981-2.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 4 Key NS. Efficacy of recombinant factor VIIa (rFVIIa) when administered in the home to control joint, muscle and mucocutaneous bleeds in hemophiliacs with inhibitors (abstr).. XVIth Congress of the Int Soc Thromb Haemost 1997.
    PubMedGoogle Scholar
  • 5 Rabelink TJ, Zwaginga JJ, Koomans HA, Sixma JJ. Thrombosis and hemostasis in renal disease.. Kidney Int 1994; 46: 287-96.
    CrossrefPubMedGoogle Scholar
  • 6 Monroe DM, Hoffman M, Oliver JA, Roberts HR. Platelet activity of high-dose factor VIIa is independent of tissue factor.. Brit J Haematol 1998; 99: 542-7.
    PubMedGoogle Scholar